HEALTH● LOWSep 21 · Sep 21, 2026, 3:43 PM
J&J sees positive late-stage data for Caplyta in reducing bipolar manic symptoms
Seeking Alpha Tech · global
Johnson & Johnson has reported positive results from late-stage clinical trials for Caplyta, indicating its effectiveness in reducing bipolar manic symptoms. This could lead to a new treatment option for bipolar disorder.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH31m agoSuspected Fake Surgeon Arrested In Rivers State, Eight Facilities SealedChannels TVHEALTH34m agoMental health at work starts by breaking the taboo, EU agency saysEuroNews [en]HEALTH52m agoUCH resident doctors suspend warning strikeVanguard NigeriaHEALTH54m agoEssential items to stock in your medicine cabinet for cold and flu seasonNPR News